Yu Z, Shang Z, Huang Q, Wu H, Patil S
Drug Des Devel Ther. 2024; 18:4889-4899.
PMID: 39512267
PMC: 11542494.
DOI: 10.2147/DDDT.S491972.
Karpa V, Kalinderi K, Fidani L, Tragiannidis A
Hematol Rep. 2023; 15(4):634-650.
PMID: 37987321
PMC: 10660515.
DOI: 10.3390/hematolrep15040065.
Dashti M, Al-Matrouk A, Channanath A, Al-Mulla F, Thanaraj T
Sci Rep. 2022; 12(1):14858.
PMID: 36050458
PMC: 9437070.
DOI: 10.1038/s41598-022-19318-x.
Alhawari H, Jarrar Y, AlKhatib M, Alhawari H, Momani M, Zayed A
Life (Basel). 2020; 10(10).
PMID: 33027917
PMC: 7599896.
DOI: 10.3390/life10100232.
Duan L, Bai Y, Li M, Li H, Li Y, Liu H
BMC Med Genet. 2019; 20(1):183.
PMID: 31727004
PMC: 6857243.
DOI: 10.1186/s12881-019-0918-4.
Influence of the OATP Polymorphism on the Population Pharmacokinetics of Methotrexate in Chinese Patients.
Wang Z, Zhang N, Chen C, Chen S, Xu J, Zhou Y
Curr Drug Metab. 2019; 20(7):592-600.
PMID: 31267867
PMC: 6857112.
DOI: 10.2174/1389200220666190701094756.
Influence of OATP1B1 and OATP1B3 mutations and glomerular filtration rate on trough serum digoxin concentration in the Chinese population: A prospective cohort study.
Chen S, Ding W, Zhang N, Xiang Q, Cui Y, Zhao X
Medicine (Baltimore). 2019; 98(14):e15088.
PMID: 30946364
PMC: 6456138.
DOI: 10.1097/MD.0000000000015088.
Therapeutic Risk and Benefits of Concomitantly Using Herbal Medicines and Conventional Medicines: From the Perspectives of Evidence Based on Randomized Controlled Trials and Clinical Risk Management.
Zhang X, Chen M, Zhu L, Zhou Q
Evid Based Complement Alternat Med. 2017; 2017:9296404.
PMID: 28491115
PMC: 5405391.
DOI: 10.1155/2017/9296404.
Hyperbilirubinemia in Neonates: Types, Causes, Clinical Examinations, Preventive Measures and Treatments: A Narrative Review Article.
Ullah S, Rahman K, Hedayati M
Iran J Public Health. 2016; 45(5):558-68.
PMID: 27398328
PMC: 4935699.
Frequencies of single-nucleotide polymorphisms and haplotypes of the SLCO1B1 gene in selected populations of the western balkans.
Grapci A, Dimovski A, Kapedanovska A, Vavlukis M, Eftimov A, Geshkovska N
Balkan J Med Genet. 2016; 18(1):5-21.
PMID: 26929901
PMC: 4768821.
DOI: 10.1515/bjmg-2015-0001.
SLCO1B1 Variants and Angiotensin Converting Enzyme Inhibitor (Enalapril)-Induced Cough: a Pharmacogenetic Study.
Luo J, He F, Wang Z, Sun N, Wang L, Tang G
Sci Rep. 2015; 5:17253.
PMID: 26607661
PMC: 4660479.
DOI: 10.1038/srep17253.
Pharmacokinetic Properties of Single- and Multiple-Dose Pitavastatin Calcium Tablets in Healthy Chinese Volunteers.
Luo Z, Zhang Y, Gu J, Feng P, Wang Y
Curr Ther Res Clin Exp. 2015; 77:52-7.
PMID: 26082816
PMC: 4460194.
DOI: 10.1016/j.curtheres.2015.02.001.
Association of CYP2D6*10, OATP1B1 A388G, and OATP1B1 T521C polymorphisms and overall survival of breast cancer patients after tamoxifen therapy.
Zhang X, Pu Z, Ge J, Shen J, Yuan X, Xie H
Med Sci Monit. 2015; 21:563-9.
PMID: 25701109
PMC: 4345853.
DOI: 10.12659/MSM.893473.
Polymorphic variants of SLCO1B1 in neonatal hyperbilirubinemia in China.
Liu J, Long J, Zhang S, Fang X, Luo Y
Ital J Pediatr. 2013; 39:49.
PMID: 24090270
PMC: 3750622.
DOI: 10.1186/1824-7288-39-49.
Genotyping of OATP2 Variants in a Group of Malaysian Neonates Using High-Resolution Melting Analysis.
Wong F, Boo N, Othman A
Biores Open Access. 2013; 1(2):92-6.
PMID: 23514972
PMC: 3559239.
DOI: 10.1089/biores.2012.0219.
Individualized therapy for type 2 diabetes: clinical implications of pharmacogenetic data.
Mannino G, Sesti G
Mol Diagn Ther. 2012; 16(5):285-302.
PMID: 23018631
DOI: 10.1007/s40291-012-0002-7.
Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response.
Rodrigues A, Perin P, Purim S, Silbiger V, Genvigir F, Willrich M
Int J Mol Sci. 2011; 12(9):5815-27.
PMID: 22016628
PMC: 3189752.
DOI: 10.3390/ijms12095815.
Effects of SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of repaglinide in healthy Chinese volunteers.
He J, Qiu Z, Li N, Yu Y, Lu Y, Han D
Eur J Clin Pharmacol. 2011; 67(7):701-7.
PMID: 21327909
DOI: 10.1007/s00228-011-0994-7.
Lack of effect of genetic polymorphisms of SLCO1B1 on the lipid-lowering response to pitavastatin in Chinese patients.
Yang G, Yuan H, Tang B, Zhang W, Wang L, Huang Z
Acta Pharmacol Sin. 2010; 31(3):382-6.
PMID: 20140004
PMC: 4002408.
DOI: 10.1038/aps.2009.203.
Prediction of hepatic clearance in human from in vitro data for successful drug development.
Chiba M, Ishii Y, Sugiyama Y
AAPS J. 2009; 11(2):262-76.
PMID: 19408130
PMC: 2691463.
DOI: 10.1208/s12248-009-9103-6.